AI assistant
Sending…
RESMED INC — Director's Dealing 2018
May 10, 2018
30071_dirs_2018-05-10_029b9862-2180-430f-a271-1f7795143b64.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-05-08
Reporting Person: PACE GARY W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-08 | ResMed Common Stock | M | 28403 | $27.58 | Acquired | 128981 | Direct |
| 2018-05-08 | ResMed Common Stock | S | 28403 | $97.37 | Disposed | 100578 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-08 | ResMed Stock Options | $27.58 | M | 28403 | Disposed | 2018-11-16 | ResMed Common Stock (28403) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $96.99 to $97.87. The price reported above reflects the weighted average sale price.
F2: Represents date options first became exercisable.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29